| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 73.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 75.255 | 0 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 73.901 | 415 | 204 | 496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 1.353 | -415 | -138 | -496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 1.137 | -415 | -140 | -496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Opticris Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 35.160 | 1.872 | 1.323 | 108 | 106 | 104 | 101 | 102 | 101 | 101 |
| Inventories | 92 | 91 | 90 | 88 | 86 | 85 | 83 | 83 | 83 | 82 |
| Receivables | 29.799 | 1.249 | 1.220 | 16 | 16 | 16 | 15 | 15 | 15 | 15 |
| Cash | 5.269 | 532 | 13 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Shareholders Funds | 26.762 | -362 | -496 | -982 | -963 | -945 | -924 | -927 | -924 | -919 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.397 | 2.234 | 1.819 | 1.090 | 1.069 | 1.049 | 1.025 | 1.028 | 1.025 | 1.020 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Opticris Med S.r.l.